info@mail.ucallm.com
From Macrophage Identity to Functional Polarization — Empowering Comprehensive Investigation of Inflammatory Signaling, Tissue Remodeling & Tumor–Immune Interactions
Macrophages are highly heterogeneous and plastic innate immune cells that continuously adapt their phenotype and function in response to cytokine environments, pathogen-associated signals, metabolic conditions, tissue-derived factors, and disease-associated stimuli.
Rather than existing as discrete activation states, macrophage phenotypes represent a dynamic functional continuum shaped by integrated regulation of:
Macrophage lineage identity and tissue-specific specialization
Inflammatory and immunoregulatory activation programs
Pattern-recognition receptor and cytokine-mediated signaling pathways
Transcriptional regulation and epigenetic remodeling
Metabolic adaptation and immunometabolic reprogramming
Extracellular matrix remodeling and tissue repair responses
Tumor-associated macrophage (TAM) functional states and immune microenvironment interactions
Macrophage functional diversity plays essential roles in maintaining tissue homeostasis while contributing to disease progression when dysregulated.
Aberrant macrophage activation and reprogramming are associated with a broad range of pathological processes, including:
Chronic inflammatory disorders and autoimmune diseases
Cancer development, immune evasion, and therapeutic resistance
Fibrotic diseases and pathological tissue remodeling
Metabolic dysfunction and obesity-associated inflammation
Infectious disease and host–pathogen interactions
Tissue injury, regeneration, and repair mechanisms
Neuroinflammation and degenerative disease progression
Our validated antibody solutions enable researchers to move beyond single-marker detection toward multiparametric profiling of macrophage populations, activation programs, signaling mechanisms, spatial distribution, and disease-associated functional remodeling.
Macrophage Polarization & Functional Reprogramming Antibody Portfolio
—Comprehensive Solutions for Profiling Macrophage Identity, Polarization Programs, Signaling Networks & Disease-Associated Functional States
Macrophages are highly plastic immune cells that continuously adapt their phenotype and function in response to cytokine signals, innate immune activation, metabolic cues, tissue microenvironment, and disease-associated stimuli.
Macrophage functional states are determined not only by polarization-associated marker expression, but also by coordinated regulation of:
Lineage identity and cellular heterogeneity
Inflammatory and immunoregulatory activation programs
Cytokine-driven signaling pathways
Metabolic and transcriptional reprogramming
Tissue remodeling and immune microenvironment interactions
Research Focus | Representative Targets | Biological Interpretation |
Macrophage Identity & Heterogeneity | CSF1R, CD68, CD11b, CD64, F4/80, AIF1, CX3CR1 | Macrophage lineage, tissue distribution and population heterogeneity |
Inflammatory Activation | CD80, CD86, NOS2, TNF, IL-1β, IL-6, PTGS2/COX-2 | Inflammatory effector programs and innate immune activation |
TLR / NF-κB Signaling | TLR4, MyD88, IRAK4, TRAF6, TAK1, NF-κB p65, p-NF-κB p65, IRF5 | PRR-driven inflammatory signaling |
Cytokine Signaling & Transcriptional Regulation | IL-4Rα, JAK1/2, STAT1, p-STAT1, STAT3, p-STAT3, STAT6, p-STAT6, IRF4 | Cytokine-dependent macrophage functional reprogramming |
Immunoregulatory / Tissue-Associated Programs | CD163, MRC1/CD206, ARG1, PPARγ, IL-10, TGF-β1, MERTK | Immune regulation, efferocytosis and tissue adaptation |
Immunometabolic Reprogramming | AMPKα, p-AMPKα, mTOR, p-mTOR, HIF-1α, GLUT1, HK2, PFKFB3, LDHA, CD36, CPT1A, FASN, NRF2 | Metabolic adaptation and metabolic control of macrophage states |
TAM Heterogeneity | TREM2, SPP1, C1QC, APOE, MARCO, CD163, MRC1, PD-L1, CCL22 | Tumor-associated macrophage states and TME interactions |
Inflammasome / Inflammatory Stress | NLRP3, ASC, Cleaved Caspase-1, IL-1β, IL-18, GSDMD | Inflammasome activation and inflammatory cell death |
Phagocytosis / Efferocytosis | CD64, MerTK, AXL, TIM4, FCGR2A/B, FCGR3A | Phagocytic and efferocytic macrophage functions |
Tissue Remodeling & Fibrosis | TGF-β1, MMP9, MMP12, VEGF, FN1, COL1A1, COL3A1, ACTA2/α-SMA | ECM remodeling, fibrosis, angiogenesis and tissue repair |
Featured Macrophage Polarization Research Panels
—Focused Antibody Panels for Mapping Macrophage Phenotype, Signaling & Functional Remodeling
From macrophage identity to disease-associated functional states, these focused panels enable multiparametric characterization of macrophage polarization across inflammatory, tissue-repair, and tumor microenvironments.
n Macrophage Identity & Polarization Core Panel—Define macrophage populations and characterize polarization-associated phenotypes
CD68 | F4/80 | CD11b | CD80 | CD86 |
CD206 | CD163 | iNOS/NOS2 | ARG1 | CSF1R |
n Inflammatory Activation & Innate Signaling Panel—Characterize inflammatory activation and innate immune signaling
TLR4 | MyD88 | NF-κB/p65 | p-NF-κB | IRAK4 |
TRAF6 | IRF5 | STAT1 | p-STAT1 | NOS2 |
n Immunoregulatory & Tissue-Repair Macrophage Panel—Investigate alternative activation, immunoregulation and tissue remodeling
IL-4Rα | STAT6 | p-STAT6 | CD206 | CD163 |
ARG1 | PPARγ | IL-10 | TGF-β1 | MERTK |
n TAM Heterogeneity & Tumor Microenvironment Panel—Profile macrophage states associated with tumor progression and immune suppression
CSF1R | CD163 | CD206 | TREM2 | SPP1 | C1QC | PD-L1 |
MARCO | CCL22 | VEGF |
|
|
|
|
n Macrophage Signaling & Metabolic Reprogramming Panel—Connect macrophage polarization with intracellular signaling and metabolic adaptation
AMPK | p-AMPK | mTOR | p-mTOR | HIF-1α | CPT1A |
GLUT1 | HK2 | PFKFB3 | LDHA | CD36 | NRF2 |
Why Researchers Choose Our Macrophage Polarization Research Solutions
Integrated Antibody Solutions for Mapping Macrophage Identity, Polarization & Functional State
Macrophage biology requires more than measuring a single polarization marker. Phenotype, signaling activity, tissue localization, and functional state must be interpreted together to accurately characterize macrophage responses.
Our validated antibody portfolio enables researchers to address key questions across macrophage research:
Research Question | Integrated Antibody Solution |
How do I identify macrophages in complex tissues? | Macrophage identity profiling — CD68, F4/80, CD11b combined with tissue- and cell-type markers |
How can I characterize macrophage polarization? | Multiparametric phenotype profiling — CD80/CD86/iNOS with CD163/CD206/ARG1 to assess inflammatory and immunoregulatory programs |
What signaling pathways drive macrophage activation? | Pathway activation profiling — TLR4–MyD88–NF-κB and IL-4Rα–STAT6 signaling with phospho-specific antibodies |
How does macrophage metabolism influence phenotype? | Immunometabolic profiling — AMPK, mTOR, HIF-1α, NRF2, PPARγ/δ and associated signaling markers |
How do macrophages contribute to the tumor microenvironment? | TAM profiling — CD163, CD206, ARG1, CCL22, TGF-β1, PD-L1 combined with tumor and immune markers |
Where are macrophages and polarization states located? | Spatial macrophage profiling — Multiplex IF/IHC enables simultaneous visualization of macrophage populations, polarization markers, and tissue architecture |
How can I validate macrophage signaling mechanisms? | Orthogonal validation — WB, ICC/IF, IHC, Flow Cytometry, Multiplex IF and PLA for complementary expression, localization, and protein-interaction analysis |
Key reference
1. Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, Rao L, Duo Y. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023 May 22;8(1):207.
2. Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, Lin L. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024 Feb 10;8(1):31.
3. Rannikko JH, Hollmén M. Clinical landscape of macrophage-reprogramming cancer immunotherapies. Br J Cancer. 2024 Sep;131(4):627-640.
4. Bai X, Guo YR, Zhao ZM, Li XY, Dai DQ, Zhang JK, Li YS, Zhang CD. Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies. Cancer Lett. 2025 Aug 10;625:217772.
5. Luo M, Zhao F, Cheng H, Su M, Wang Y. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024 Apr 10;15:1352946.
6. Wang C, Ma C, Gong L, Guo Y, Fu K, Zhang Y, Zhou H, Li Y. Macrophage Polarization and Its Role in Liver Disease. Front Immunol. 2021 Dec 14;12:803037.
7. Cutolo M, Campitiello R, Gotelli E, Soldano S. The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. Front Immunol. 2022 May 19;13:867260.